This study identified a feature of the epileptic brain that evolves slowly and differs fundamentally in well-controlled and poorly controlled epilepsy.
A subset of epilepsy cases of unknown etiology may be secondary to the production of autoantibodies.
Despite recommendations, many patients in the cohort were prescribed older antiepileptic drugs.
Patients who participated in a group course with other people with epilepsy felt less isolated and more confident.
A diagnosis of maternal epilepsy alone was not associated with an increase in congenital malformations in offspring.
Quality improvement measures help to reduce emergency department visits, inpatient hospitalizations, and health care claims.
Patients with both MS and epileptic seizures had a younger age at onset of MS compared with those without seizures.
Brain oxygenation may be compromised during periodic discharges, ultimately warranting treatment.
Nearly 60% of patients had achieved seizure freedom at last follow-up, 10 to 21 years after surgery.
Careful monitoring of EEG patterns is a useful way to stratify seizure risk in critically ill patients.
The results confirm the effectiveness and safety of low-dose CBZ as a first-line agent for the treatment of neonatal seizures.
Greater spasm cessation was achieved in the combination group vs those who received hormonal therapy alone.
Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.
Shaun Hussain, MD, MS, discusses a gap in health care provider knowledge that may contribute to the delay in the diagnosis and treatment of infantile spasms.
Elizabeth Thiele, MD, PhD discusses results from her research on cannabidiol in Lennox-Gastaut syndrome.
Clobazam had been previously identified as an AED with a significant interaction with CBD.
Justin Gover, CEO of GW Pharmaceuticals, the parent company of Greenwich Biosciences, discusses the status of the company's cannabidiol product Epidiolex on the heels of positive results from several placebo-controlled trials in epileptic syndromes.
Number of AEDs and seizure frequency also influenced depression in people with epilepsy.
Concordant EEG/fMRI and ESI predicted outcomes with 100% sensitivity and specificity.
Adjunctive everolimus treatment has been found to significantly reduce frequency of treatment-resistant seizures in TSC.
Neurology Advisor Articles
- Cannabis: Current Evidence and Research Recommendations
- Addressing Gender Differences in Concussion Diagnosis and Treatment
- Relapsing-Remitting Multiple Sclerosis Halted With Immunosuppression, Stem Cell Transplant
- Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring
- In Stroke, No Clear Benefit for Head Positioning